Patents by Inventor Catherine Souaille

Catherine Souaille has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8058290
    Abstract: The disclosure relates to compounds of formula (I): which modulate the activity of proteins, particularly kinases, and to compositions containing the same, and to the use thereof as medicaments, in particular as anticancer agents.
    Type: Grant
    Filed: January 29, 2008
    Date of Patent: November 15, 2011
    Assignee: Aventis Pharma S.A.
    Inventors: Kirsten Bjergarde, Anil Nair, Marcel Patek, Martha Ackerman-Berrier, Martin Smrcina, Eric Bacque, Michel Tabart, Baptiste Ronan, Vincent Leroy, Fabrice Viviani, Mark Dodson, Catherine Souaille
  • Patent number: 8008322
    Abstract: The disclosure relates to substituted pyrazolo-pyridines, compositions containing them, methods for the production thereof, and to their use as medicaments, in particular, as anticancer agents.
    Type: Grant
    Filed: July 17, 2007
    Date of Patent: August 30, 2011
    Assignee: Aventis Pharma S.A.
    Inventors: Baptiste Ronan, Michel Tabart, Frank Halley, Eric Bacque, Catherine Souaille, Antonio Ugolini, Fabrice Viviani
  • Publication number: 20110190337
    Abstract: The disclosure relates to substituted pyrazolo-pyridines, compositions containing them, methods for the production thereof, and to their use as medicaments, in particular, as anticancer agents.
    Type: Application
    Filed: April 11, 2011
    Publication date: August 4, 2011
    Applicant: AVENTIS PHARMA S.A..
    Inventors: Baptiste RONAN, Michel TABART, Frank HALLEY, Eric BACQUE, Catherine SOUAILLE, Antonio UGOLINI, Fabrice VIVIANI
  • Patent number: 7947706
    Abstract: The invention relates to compounds of formula (I): wherein Ra, R1, Ar, L, A, W, Y, and Z are as defined in the disclosure; to compositions containing them; and to the preparation and use thereof, in particular as anticancer agents.
    Type: Grant
    Filed: October 11, 2007
    Date of Patent: May 24, 2011
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Michel Tabart, Eric Bacque, Frank Halley, Baptiste Ronan, Pascal Desmazeau, Fabrice Viviani, Catherine Souaille
  • Patent number: 7592365
    Abstract: The disclosure concerns substituted pyrroles of formula (I): wherein A, L, Ar, R1, R2, R5, and Ra are as defined in the disclosure, compositions containing the same, methods for making the same and uses thereof, in particular as anti-cancer agents.
    Type: Grant
    Filed: August 1, 2007
    Date of Patent: September 22, 2009
    Assignee: Aventis Pharma S.A.
    Inventors: Baptiste Ronan, Michel Tabart, Catherine Souaille, Fabrice Viviani, Eric Bacque, Jean-Philippe Letallec, Pascal Desmazeau
  • Patent number: 7566736
    Abstract: Compounds of formula (I): wherein R1, R5, R6, R7, Ar, L, A, and Q are as defined in the description, and to salts thereof, to compositions containing them, to the process for preparing them, and to their use as medicinal products, in particular as anticancer agents.
    Type: Grant
    Filed: June 4, 2007
    Date of Patent: July 28, 2009
    Assignee: Aventis Pharma S.A.
    Inventors: Frank Halley, Catherine Souaille, Michel Tabart, Eric Bacque, Fabrice Viviani, Baptiste Ronan, Jean-Philippe Letallec, Bruno Filoche-Rommé
  • Patent number: 7560571
    Abstract: The disclosure concerns substituted imidazoles and pyrroles, compositions containing the same, the preparation thereof, and the use thereof as medicaments, particularly as anti-cancer agents.
    Type: Grant
    Filed: August 1, 2007
    Date of Patent: July 14, 2009
    Assignee: Aventis Pharma S.A.
    Inventors: Baptiste Ronan, Frank Halley, Catherine Souaille, Fabrice Viviani, Youssef El-Ahmad, Eric Bacque, Michel Tabart
  • Patent number: 7517902
    Abstract: Disclosed are novel substituted indazole compounds, pharmaceutical compositions comprising such compounds, and methods of treatment comprising such compounds.
    Type: Grant
    Filed: December 4, 2006
    Date of Patent: April 14, 2009
    Assignee: Aventis Pharma S.A.
    Inventors: Frank Halley, Michel Tabart, Hervé Bouchard, Catherine Souaille, Alain Le Brun, Fabrice Viviani, Laurence Gauzy-Lazo, Pascal Desmazeau, Odile Angouillant-Boniface, Bruno Filoche-Romme
  • Patent number: 7435820
    Abstract: Substituted tetrahydro-1H-pyrazolo[3,4-c]pyridines, compositions comprising them and use. The present invention relates in particular to novel substituted tetrahydro-1H-pyrazolo[3,4-c]pyridines having therapeutic activity, which can be used in particular in oncology.
    Type: Grant
    Filed: May 23, 2006
    Date of Patent: October 14, 2008
    Assignee: Aventis Pharma S.A.
    Inventors: Fabienne Thompson, Catherine Souaille, Fabrice Viviani, Michel Tabart, Patrick Mailliet, Teresa Damiano, Marie-Pierre Cherrier, Francois Clerc, Frank Halley, Herve Bouchard, Laurence Gauzy-Lazo, Bernard Baudoin
  • Publication number: 20080182844
    Abstract: The disclosure relates to compounds of formula (I): which modulate the activity of proteins, particularly kinases, and to compositions containing the same, and to the use thereof as medicaments, in particular as anticancer agents.
    Type: Application
    Filed: January 29, 2008
    Publication date: July 31, 2008
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Kirsten BJERGARDE, Anil NAIR, Marcel PATEK, Martha ACKERMAN-BERRIER, Martin SMRCINA, Eric BACQUE, Michel TABART, Baptiste RONAN, Vincent LEROY, Fabrice VIVIANI, Mark DODSON, Catherine SOUAILLE
  • Publication number: 20080167368
    Abstract: The disclosure concerns substituted pyrroles of formula (I): wherein A, L, Ar, R1, R2, R5, and Ra are as defined in the disclosure, compositions containing the same, methods for making the same and uses thereof, in particular as anti-cancer agents.
    Type: Application
    Filed: August 1, 2007
    Publication date: July 10, 2008
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Baptiste RONAN, Michel TABART, Catherine SOUAILLE, Fabrice VIVIANI, Eric BACQUE, Jean-Philippe LETALLEC, Pascal DESMAZEAU
  • Publication number: 20080139606
    Abstract: The invention relates to compounds of formula (I): wherein Ra, R1, Ar, L, A, W, Y, and Z are as defined in the disclosure; to compositions containing them; and to the preparation and use thereof, in particular as anticancer agents.
    Type: Application
    Filed: October 11, 2007
    Publication date: June 12, 2008
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Michel Tabart, Eric Bacque, Frank Halley, Baptiste Ronan, Pascal Desmazeau, Fabrice Viviani, Catherine Souaille
  • Publication number: 20080045542
    Abstract: The disclosure concerns substituted imidazoles and pyrroles, compositions containing the same, the preparation thereof, and the use thereof as medicaments, particularly as anti-cancer agents.
    Type: Application
    Filed: August 1, 2007
    Publication date: February 21, 2008
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Baptiste RONAN, Frank HALLEY, Catherine SOUAILLE, Fabrice VIVIANI, Youssef EL-AHMAD, Eric BACQUE, Michel TABART
  • Publication number: 20080039491
    Abstract: The disclosure relates to substituted pyrazolo-pyridines, compositions containing them, methods for the production thereof, and to their use as medicaments, in particular, as anticancer agents.
    Type: Application
    Filed: July 17, 2007
    Publication date: February 14, 2008
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Baptiste RONAN, Michel TABART, Frank HALLEY, Eric BACQUE, Catherine SOUAILLE, Antonio UGOLINI, Fabrice VIVIANI
  • Publication number: 20070259910
    Abstract: Compounds of formula (I): wherein R1, R5, R6, R7, Ar, L, A, and Q are as defined in the description, and to salts thereof, to compositions containing them, to the process for preparing them, and to their use as medicinal products, in particular as anticancer agents.
    Type: Application
    Filed: June 4, 2007
    Publication date: November 8, 2007
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Frank HALLEY, Catherine SOUAILLE, Michel TABART, Eric BACQUE, Fabrice VIVIANI, Baptiste RONAN, Jean-Philippe LETALLEC, Bruno FILOCHE-ROMME
  • Publication number: 20070161626
    Abstract: Disclosed are novel substituted indazole compounds, pharmaceutical compositions comprising such compounds, and methods of treatment comprising such compounds.
    Type: Application
    Filed: December 4, 2006
    Publication date: July 12, 2007
    Applicant: Aventis Pharma S.A.
    Inventors: Frank Halley, Michel Tabart, Herve Bouchard, Catherine Souaille, Alain Le Brun, Fabrice Viviani, Laurence Gauzy-Lazo, Pascal Desmazeau, Odile Angouillant-Boniface, Bruno Filoche-Romme
  • Patent number: 7109340
    Abstract: Substituted tetrahydro-1H-pyrazolo[3,4-c]pyridines, compositions comprising them and use. The present invention relates in particular to novel substituted tetrahydro-1H-pyrazolo[3,4-c]pyridines having therapeutic activity, which can be used in particular in oncology.
    Type: Grant
    Filed: July 9, 2004
    Date of Patent: September 19, 2006
    Assignee: Aventis Pharma S.A.
    Inventors: Fabienne Thompson, Patrick Mailliet, Teresa Damiano, Marie-Pierre Cherrier, Francois Clerc, Frank Halley, Hervé Bouchard, Laurence Gauzy-Lazo, Bernard Baudoin, Catherine Souaille, Fabrice Viviani, Michel Tabart
  • Publication number: 20050096345
    Abstract: Substituted tetrahydro-1H-pyrazolo[3,4-c]pyridines, compositions comprising them and use. The present invention relates in particular to novel substituted tetrahydro-1H-pyrazolo[3,4-c]pyridines having therapeutic activity, which can be used in particular in oncology.
    Type: Application
    Filed: July 9, 2004
    Publication date: May 5, 2005
    Applicant: Aventis Pharma S.A.
    Inventors: Fabienne Thompson, Patrick Mailliet, Teresa Damiano, Marie-Pierre Cherrier, Francois Clerc, Frank Halley, Herve Bouchard, Laurence Gauzy-Lazo, Bernard Baudoin, Catherine Souaille, Fabrice Viviani, Michel Tabart